There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
To evaluate the efficacy of lisdexamfetamine dimesylate in adults with attention deficit
hyperactivity disorder symptom subtypes who exhibit predominantly inattention, hyperactivity/
impulsivity, or combined symptom clusters.